Difference between revisions of "Sasaki H, et al. Development (1999) cited as Ref 216 in DOI: 10.1038/s41392-020-0110-5 (Q9479)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 126, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: title (P93): Regulation of Gli2 and Gli3 activities by an amino-terminal repression domain: implication of Gli2 and Gli3 as primary mediators of Shh signaling, #quickstatements; #temporary_batch_1590010982689) |
||
| Property / title | |||
| + | Regulation of Gli2 and Gli3 activities by an amino-terminal repression domain: implication of Gli2 and Gli3 as primary mediators of Shh signaling (English) | ||
| Property / title: Regulation of Gli2 and Gli3 activities by an amino-terminal repression domain: implication of Gli2 and Gli3 as primary mediators of Shh signaling (English) / rank | |||
| + | Normal rank | ||
Revision as of 21:55, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Sasaki H, et al. Development (1999) cited as Ref 216 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Sasaki H
0 references
Nishizaki Y
0 references
Hui C
0 references
1999
0 references
Development
0 references
126
0 references
Regulation of Gli2 and Gli3 activities by an amino-terminal repression domain: implication of Gli2 and Gli3 as primary mediators of Shh signaling (English)
0 references
